Related Experiment Videos
Lithium distribution in mania: single-dose pharmacokinetics and sympathoadrenal function.
A C Swann1, N Berman, A Frazer
1Department of Psychiatry, University of Texas Medical School, Houston 77225.
Psychiatry Research
|April 1, 1990
Summary
Lithium distribution in manic patients shows tissue levels rise after plasma peaks. Lithium transport correlates with sympathoadrenal activity and sodium gradients, suggesting altered distribution in mania.
Area of Science:
- Pharmacokinetics
- Neuroscience
- Psychiatry
Background:
- Lithium is a key mood stabilizer for bipolar disorder.
- Understanding lithium distribution is crucial for optimizing treatment efficacy and safety.
- Previous studies have not fully elucidated lithium's complex distribution dynamics in manic patients.
Purpose of the Study:
- To investigate lithium distribution in drug-free manic patients after a single dose.
- To analyze lithium concentrations in plasma, red blood cells, and urine.
- To estimate pharmacokinetic parameters including influx and efflux rate constants.
Main Methods:
- A single 25 mEq dose of lithium was administered to 14 drug-free manic patients.
- Lithium concentrations were measured in plasma, red blood cells, and urine.
- A three-compartment pharmacokinetic model was used to estimate rate constants for various compartments.
Main Results:
- Tissue lithium concentrations continued to increase for hours after plasma levels peaked.
- Rate constants for lithium transport correlated negatively with norepinephrine/epinephrine excretion and positively with the plasma/red cell Na+ gradient.
- Red blood cell and muscle compartment efflux rates correlated with adrenocortical function and were higher in dexamethasone non-suppressors.
Conclusions:
- Lithium distribution in manic patients is influenced by sympathoadrenal activity.
- Sodium distribution across cell membranes plays a role in lithium transport.
- Altered lithium distribution may be linked to neuroendocrine dysregulation in mania.